Pfizer Shares Bounce Between Bull And Bear
21245
Pfizer Inc.&#39;s shares continued to rebound Wednesday, gaining 4 percent during the day&#39;s trading, as industry analysts continued to sort out the most recent studies involving its Celebrex drug.
78753
Shares of Nektar Therapeutics remained active Wednesday following upgrades from two investment firms after drug giant Pfizer Inc. cited its inhalable insulin product in a recent pipeline report.
758212
As Pfizer&#39;s (PFE:NYSE - news - research) Celebrex safety hiccup was unfolding Friday, I had a running conversation with a fund manager.
733277
U.S. stocks climbed on Tuesday  supported by Pfizer Inc. PFE.N after investor fears of the  withdrawal of its arthritis drug Celebrex were calmed, while  IAC/InterActive Corp. IACI.O pushed up Nasdaq after it  announced plans to spin off its Expedia.com unit.
244370
U.S. stocks fell on Friday dragged  down by a string of negative reports from drug makers, with  Pfizer Inc. PFE.N, AstraZeneca Plc. AZN.L and Eli Lilly and  Co. LLY.N delivering bad news about key products.
303018
Pfizer Inc.  on Monday boosted  its quarterly dividend 21 percent after the surprise failure of  its most important experimental drug caused a sell- off in its  shares, and gave its new chief executive additional duties as  chairman.
277277
A Santa Claus rally pushed Wall Street&#39;s blue-chip stocks to their highest close in 3-1/2 years on Tuesday, boosted by a rebound in drugmaker Pfizer Inc.
302848
U.S. stocks rose on Monday as a slew of acquisition deals pointed to optimism about the economy, outweighing sharp losses by blue-chip Pfizer Inc. , which dropped a key experimental drug.
698972
U.S. stocks were near the unchanged  mark on Monday, pausing for breath after last week's  post-election rally as another interest rate rise loomed, while  drug maker Pfizer Inc. weighed on the Dow and S&P 500 indexes.
693310
The Pfizer painkillers Celebrex and Bextra experienced a jump in sales immediately after rival Merck&#39;s Vioxx was pulled from the market in late September, but the gains appear to be short
438179
Shares of Pfizer Inc. slipped on Wednesday, following reports that a study had likened the companyâs Bextra arthritis drug to Merck&#39;s Vioxx in terms of its cardiovascular risks.
143159
Some analysts are betting Pfizer Inc.  PFE.N won't have to withdraw its arthritis drug Celebrex but  they do expect sales to fall after a study of the drug in  cancer patients showed it increased the risk of heart attacks.
387898
Pfizer Inc, Novartis AG and Wyeth all  saw quarterly earnings hit by charges on Thursday, while Eli  Lilly and Co exceeded Wall Street expectations as third-quarter  sales of several of its drugs outpaced analysts' estimates.
261035
Pfizer Inc. shares rebounded on Tuesday as a study of Alzheimer&#39;s patients found that its arthritis drug Celebrex carried no increased cardiovascular risks, differing from
149032
The stock is feeling some pain these days. However, this drugmaker has enough going for it that the illness shouldn&#39;t last. Amid nervousness over the future of Pfizer&#39;s arthritis pain treatment Celebrex and
568209
U.S. stocks looked set to open slightly higher on Monday as a spate of acquisition deals suggested optimism about the economy, but Pfizer Inc.'s  decision to abandon a key experimental drug hammered its shares.
561772
NEW YORK  - Drugs giant Pfizer Inc.&#39;s stock fell on a report that new prescriptions for its blockbuster pain medication Celebrex slumped 56 percent last week.